atezolizumab (MPDL3280A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for atezolizumab (MPDL3280A), covering 2024-05-03 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: MPDL3280A-treatment-IST-UMCG [Phase 2]